POSITRON EMISSION TOMOGRAPHY (PET) IN BREAST CANCER DIAGNOSIS
PDF
Cite
Share
Request
Review
P: 69-72
April 2009

POSITRON EMISSION TOMOGRAPHY (PET) IN BREAST CANCER DIAGNOSIS

Eur J Breast Health 2009;5(2):69-72
1. İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Nükleer Tıp Anabilim Dalı, İstanbul, Türkiye
No information available.
No information available
Received Date: 24.10.2008
Accepted Date: 21.11.2008
PDF
Cite
Share
Request

ABSTRACT

Breast cancer is the most frequent cancer in women and is the second lethal malignancy after lung cancer. Screening mammography is widely used for its diagnosis, but it has a considerably high false negativity rate. Various factors has effects on the sensitivity of mammography and its specificity is low. MRI and ultrasonography are complementary methods for the difficult cases but there is still need for determining the benign or malignant nature of the breast masses. In this respect, nuclear medicine extended its useful contributions by scintimammography after the use of specific substances such as Tc-99m MIBI and further improved with the Positron Emission Tomography. In this review the benefits of PET in the diagnosis of breast cancer and its methods are reported

Keywords:
breast cancer, nuclear medicine, PET